CA Stock MarketDetailed Quotes

NRX NurExone Biologic Inc

Watchlist
  • 0.700
  • +0.010+1.45%
15min DelayMarket Closed Jul 5 16:00 ET
46.97MMarket Cap-6363P/E (TTM)

NurExone Biologic Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
104.97%3.26M
-78.03%541K
-78.03%541K
-63.73%1.14M
-78.10%880K
1.66%1.59M
11.25%2.46M
11.25%2.46M
--3.15M
--4.02M
-Cash and cash equivalents
104.97%3.26M
-78.03%541K
-78.03%541K
-63.73%1.14M
-78.10%880K
1.66%1.59M
11.25%2.46M
11.25%2.46M
--3.15M
--4.02M
-Due from related parties current
----
----
----
----
----
----
----
----
--0
--0
-Other receivables
-61.94%102K
-50.50%50K
-50.50%50K
-91.38%48K
-68.97%153K
-26.98%268K
-38.04%101K
-38.04%101K
--557K
--493K
Total current assets
93.42%3.68M
-26.37%1.98M
-26.37%1.98M
-62.40%1.28M
-75.75%1.07M
7.58%1.9M
-5.08%2.69M
-5.08%2.69M
--3.4M
--4.41M
Non current assets
-Accumulated depreciation
----
-1,200.00%-13K
-1,200.00%-13K
----
----
----
---1K
---1K
----
----
-Long term equity investment
84.62%24K
-90.00%2K
-90.00%2K
-88.00%3K
-75.68%9K
--13K
--20K
--20K
--25K
--37K
-Other intangible assets
64.65%2.2M
59.24%2.13M
59.24%2.13M
48.36%1.95M
29.71%1.66M
356.66%1.34M
668.39%1.34M
668.39%1.34M
--1.31M
--1.28M
Regulatory assets
50.58%390K
88.46%98K
88.46%98K
-58.38%82K
-63.81%135K
39.25%259K
-89.94%52K
-89.94%52K
--197K
--373K
Total assets
----
85.42%89K
85.42%89K
----
----
----
-27.27%48K
-27.27%48K
----
----
Liabilities
Current liabilities
Current debt and capital lease obligation
----
-25.00%18K
-25.00%18K
----
----
----
-97.70%24K
-97.70%24K
----
----
-Current capital lease obligation
----
-25.00%18K
-25.00%18K
----
----
----
--24K
--24K
----
----
-accounts payable
----
----
----
--306K
----
----
----
----
----
----
-Total tax payable
83.95%149K
-23.16%73K
-23.16%73K
-39.09%67K
-22.94%84K
28.57%81K
239.29%95K
239.29%95K
--110K
--109K
-Due to related parties current
----
--0
--0
----
----
----
--22K
--22K
----
----
-Other payable
----
----
----
----
----
----
--1K
--1K
----
----
Current accrued expenses
-23.26%231K
20.18%548K
20.18%548K
89.44%269K
70.06%284K
--301K
149.18%456K
149.18%456K
--142K
--167K
Current deferred liabilities
--29K
--95K
--95K
----
----
----
--0
--0
----
----
Current liabilities
-36.38%362K
216.42%1.91M
216.42%1.91M
-10.87%623K
-33.79%437K
-63.94%569K
-63.03%603K
-63.03%603K
--699K
--660K
Non current liabilities
-Long term debt
84.62%24K
-90.00%2K
-90.00%2K
-88.00%3K
-75.68%9K
--13K
--20K
--20K
--25K
--37K
Non current accrued expenses
225.17%465K
86.14%188K
86.14%188K
15.79%132K
27.93%142K
--143K
--101K
--101K
--114K
--111K
Total non current liabilities
-21.38%511K
183.81%1.98M
183.81%1.98M
-14.71%690K
-32.25%521K
-60.39%650K
-57.93%698K
-57.93%698K
--809K
--769K
Shareholders'equity
Share capital
--0
--0
--0
--0
--0
--0
--0
--0
--75K
--75K
-common stock
--0
--0
--0
--0
--0
--0
--0
--0
--75K
--75K
Additional paid-in capital
46.38%16.5M
8.11%12.16M
8.11%12.16M
12.29%12.16M
4.39%11.28M
159.38%11.27M
245.41%11.25M
245.41%11.25M
--10.83M
--10.8M
Retained earnings
-40.74%32K
2,175.93%1.23M
2,175.93%1.23M
0.00%54K
217.65%54K
184.21%54K
184.21%54K
184.21%54K
--54K
--17K
Gains losses not affecting retained earnings
1.10%-90K
38.36%-45K
38.36%-45K
40.59%-60K
-86.67%-84K
---91K
-1,360.00%-73K
-1,360.00%-73K
---101K
---45K
Total equity
102.64%4.14M
-22.33%2.17M
-22.33%2.17M
-59.87%1.41M
-73.20%1.21M
15.68%2.04M
-1.48%2.79M
-1.48%2.79M
--3.52M
--4.52M
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 104.97%3.26M-78.03%541K-78.03%541K-63.73%1.14M-78.10%880K1.66%1.59M11.25%2.46M11.25%2.46M--3.15M--4.02M
-Cash and cash equivalents 104.97%3.26M-78.03%541K-78.03%541K-63.73%1.14M-78.10%880K1.66%1.59M11.25%2.46M11.25%2.46M--3.15M--4.02M
-Due from related parties current ----------------------------------0--0
-Other receivables -61.94%102K-50.50%50K-50.50%50K-91.38%48K-68.97%153K-26.98%268K-38.04%101K-38.04%101K--557K--493K
Total current assets 93.42%3.68M-26.37%1.98M-26.37%1.98M-62.40%1.28M-75.75%1.07M7.58%1.9M-5.08%2.69M-5.08%2.69M--3.4M--4.41M
Non current assets
-Accumulated depreciation -----1,200.00%-13K-1,200.00%-13K---------------1K---1K--------
-Long term equity investment 84.62%24K-90.00%2K-90.00%2K-88.00%3K-75.68%9K--13K--20K--20K--25K--37K
-Other intangible assets 64.65%2.2M59.24%2.13M59.24%2.13M48.36%1.95M29.71%1.66M356.66%1.34M668.39%1.34M668.39%1.34M--1.31M--1.28M
Regulatory assets 50.58%390K88.46%98K88.46%98K-58.38%82K-63.81%135K39.25%259K-89.94%52K-89.94%52K--197K--373K
Total assets ----85.42%89K85.42%89K-------------27.27%48K-27.27%48K--------
Liabilities
Current liabilities
Current debt and capital lease obligation -----25.00%18K-25.00%18K-------------97.70%24K-97.70%24K--------
-Current capital lease obligation -----25.00%18K-25.00%18K--------------24K--24K--------
-accounts payable --------------306K------------------------
-Total tax payable 83.95%149K-23.16%73K-23.16%73K-39.09%67K-22.94%84K28.57%81K239.29%95K239.29%95K--110K--109K
-Due to related parties current ------0--0--------------22K--22K--------
-Other payable --------------------------1K--1K--------
Current accrued expenses -23.26%231K20.18%548K20.18%548K89.44%269K70.06%284K--301K149.18%456K149.18%456K--142K--167K
Current deferred liabilities --29K--95K--95K--------------0--0--------
Current liabilities -36.38%362K216.42%1.91M216.42%1.91M-10.87%623K-33.79%437K-63.94%569K-63.03%603K-63.03%603K--699K--660K
Non current liabilities
-Long term debt 84.62%24K-90.00%2K-90.00%2K-88.00%3K-75.68%9K--13K--20K--20K--25K--37K
Non current accrued expenses 225.17%465K86.14%188K86.14%188K15.79%132K27.93%142K--143K--101K--101K--114K--111K
Total non current liabilities -21.38%511K183.81%1.98M183.81%1.98M-14.71%690K-32.25%521K-60.39%650K-57.93%698K-57.93%698K--809K--769K
Shareholders'equity
Share capital --0--0--0--0--0--0--0--0--75K--75K
-common stock --0--0--0--0--0--0--0--0--75K--75K
Additional paid-in capital 46.38%16.5M8.11%12.16M8.11%12.16M12.29%12.16M4.39%11.28M159.38%11.27M245.41%11.25M245.41%11.25M--10.83M--10.8M
Retained earnings -40.74%32K2,175.93%1.23M2,175.93%1.23M0.00%54K217.65%54K184.21%54K184.21%54K184.21%54K--54K--17K
Gains losses not affecting retained earnings 1.10%-90K38.36%-45K38.36%-45K40.59%-60K-86.67%-84K---91K-1,360.00%-73K-1,360.00%-73K---101K---45K
Total equity 102.64%4.14M-22.33%2.17M-22.33%2.17M-59.87%1.41M-73.20%1.21M15.68%2.04M-1.48%2.79M-1.48%2.79M--3.52M--4.52M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg